Newsletter Archive
-
12.03.24 -- How To Overcome Immune Rejection In iPSC-based Gene Therapy
12/3/2024
12/03/24 Drug Discovery Online Newsletter
-
12.02.24 -- Streamline Your Oral Drug Development Process
12/2/2024
12/02/24 Drug Discovery Online Newsletter
-
11.27.24 -- Find The Perfect CDMO Partner For Your Project
11/27/2024
11/27/24 Drug Discovery Online Newsletter
-
11.26.24 -- Emerging Partnership Trends In Oligo-Based Medicines
11/26/2024
11/26/24 Drug Discovery Online Newsletter
-
11.25.24 -- Choosing The Ideal CDMO Partner For Your Project
11/25/2024
11/25/24 Drug Discovery Online Newsletter
-
11.22.24 -- Picking The Right CDMO Partner For Your Project
11/22/2024
11/22/24 Drug Discovery Online Newsletter
-
11.19.24 -- Panavance Details IND Prep Ahead Of FDA Submission For Ovarian Cancer Trial
11/19/2024
11/19/24 Drug Discovery Online Newsletter
-
11.14.24 -- Take The Next Step Towards Scaling-Up
11/14/2024
11/14/24 Drug Discovery Online Newsletter
-
11.13.24 -- Building Resilience In Drug Development: Cost-Efficient Solutions With CDMOs
11/13/2024
11/13/24 Drug Discovery Online Newsletter
-
11.12.24 -- iPSC-based Gene Therapy: Applications And Challenges
11/12/2024
11/12/24 Drug Discovery Online Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more